DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
Impact of Nurse Case Management on Diabetes Co-morbidities
2 other identifiers
interventional
550
1 country
2
Brief Summary
Although strong clinical evidence exists that patients with diabetes should achieve certain clinical goals (i.e. HbA1C, BP, LDL, etc.), to reduce morbidity and mortality national surveys indicate that only a minority of people with diabetes achieves these goals. Hypothesis: combination of nurse case management and enhanced behavior change counseling will improve outcomes for glycemic control, blood pressure and cholesterol in high risk patients with Type 2 diabetes when compared to usual care over a 3 year period. Study design- The study will be a three year randomized control trial that will select patients that have either A1C \>8.5, LDL \>130, or BP \>140/90. Nurse case managers, trained in clinical guidelines and brief behavior change counseling techniques (motivational interviewing), will aim to foster patient adherence in the experimental group patients. Nurse case managers will use standing orders to set an implementation of clinical guidelines (for diabetes, hypertension, hyperlipidemia and depression) with individual follow up. A total of 820 patients between the all 9 (6 Hershey Medical Center and 3 Reading Hospital affiliated clinics) will be sought. One third of the study patients will be recruited from the underserved Hispanic population in the Reading area. Patients will be randomized by physician i.e. one physician will be randomly assigned to have all their patients co-managed by a nurse case manager; the other will have usual care without any contact with nurse case manager. Nurses will be trained and then initiate a small pilot study in July thru August. Full recruitment and initiation of study will begin in September 2006. Clinic Activities - Each nurse will be responsible for 3 clinics. Nurses will work under the supervision of the primary care physicians. A set of clinical guidelines will be developed with physician input that will serve as the over-riding framework for the nurses. Outcomes - Over a three-year period the investigators will evaluate clinical response (improvements in A1C, BP, LDL, and depression when present) as well as a series of other measures that will be obtained by surveys (patient satisfaction, quality of life, self-management behaviors). Provider satisfaction will be measured using a standardized tool. Finally, cost effectiveness of the intervention and evaluation of the potential barriers to implementation will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 diabetes-mellitus
Started Aug 2006
Longer than P75 for phase_3 diabetes-mellitus
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2006
CompletedFirst Posted
Study publicly available on registry
March 29, 2006
CompletedStudy Start
First participant enrolled
August 10, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2011
CompletedFebruary 20, 2019
February 1, 2019
5 years
March 27, 2006
February 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
% of patients reaching goal HbA1C (<7)
2 years after enrollment
% of patients with BP goal (<130/80)
Two years after enrollment
% of patients with LDL at goal (<100)
2 years after enrollment
% of patients at goal for all three parameters (HbA1C <7, BP <130/80, LDL <100)
2 years after enrollment
Secondary Outcomes (13)
% of patients with yearly ophthalmologic exam
2 years after enrollment
% of patients with yearly foot exam
2 years after enrollment
% of patients with assessment for nephropathy
2 years after enrollment
% of patients with nephropathy on ACE inhibitor or ARB
2 years after enrollment
% of patients on aspirin
2 years after enrollment
- +8 more secondary outcomes
Interventions
Intervention is meeting with nurse case managers
Eligibility Criteria
You may qualify if:
- Type 2 diabetes
- age \> 18 years old who are at high risk based on any one of the following criteria:
- HbA1C \> 8.5
- LDL \> 130
- BP \> 140/90 within the last 6 months
You may not qualify if:
- patients who are pregnant upon entry in the study (however if a patient becomes pregnant in the course of the study, she can continue with the study)
- unable to communicate in either English or Spanish
- in nursing homes (and therefore unable to attend outpatient visits)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Penn State College of Medicine
Hershey, Pennsylvania, 17033, United States
Reading Hospital
Reading, Pennsylvania, 19612, United States
Related Publications (2)
Gabbay RA, Lendel I, Saleem TM, Shaeffer G, Adelman AM, Mauger DT, Collins M, Polomano RC. Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res Clin Pract. 2006 Jan;71(1):28-35. doi: 10.1016/j.diabres.2005.05.002. Epub 2005 Jul 12.
PMID: 16019102BACKGROUNDStuckey HL, Dellasega C, Graber NJ, Mauger DT, Lendel I, Gabbay RA. Diabetes nurse case management and motivational interviewing for change (DYNAMIC): study design and baseline characteristics in the Chronic Care Model for type 2 diabetes. Contemp Clin Trials. 2009 Jul;30(4):366-74. doi: 10.1016/j.cct.2009.03.002. Epub 2009 Mar 26.
PMID: 19328244DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Gabbay, MD, PhD
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2006
First Posted
March 29, 2006
Study Start
August 10, 2006
Primary Completion
July 27, 2011
Study Completion
July 27, 2011
Last Updated
February 20, 2019
Record last verified: 2019-02